QQQ   311.31 (+3.45%)
AAPL   150.14 (+3.24%)
MSFT   261.46 (+3.45%)
META   193.14 (+26.14%)
GOOGL   106.52 (+6.06%)
AMZN   112.67 (+7.15%)
TSLA   193.18 (+6.49%)
NVDA   216.35 (+3.30%)
NIO   12.19 (+0.74%)
BABA   108.92 (-3.46%)
AMD   88.02 (+3.99%)
T   20.39 (+1.04%)
MU   63.21 (+0.97%)
F   14.48 (+5.00%)
CGC   3.16 (+2.60%)
GE   83.60 (+1.55%)
DIS   112.78 (+3.10%)
AMC   6.30 (+10.33%)
PFE   44.13 (+0.36%)
PYPL   88.04 (+6.19%)
NFLX   365.14 (+0.87%)
QQQ   311.31 (+3.45%)
AAPL   150.14 (+3.24%)
MSFT   261.46 (+3.45%)
META   193.14 (+26.14%)
GOOGL   106.52 (+6.06%)
AMZN   112.67 (+7.15%)
TSLA   193.18 (+6.49%)
NVDA   216.35 (+3.30%)
NIO   12.19 (+0.74%)
BABA   108.92 (-3.46%)
AMD   88.02 (+3.99%)
T   20.39 (+1.04%)
MU   63.21 (+0.97%)
F   14.48 (+5.00%)
CGC   3.16 (+2.60%)
GE   83.60 (+1.55%)
DIS   112.78 (+3.10%)
AMC   6.30 (+10.33%)
PFE   44.13 (+0.36%)
PYPL   88.04 (+6.19%)
NFLX   365.14 (+0.87%)
QQQ   311.31 (+3.45%)
AAPL   150.14 (+3.24%)
MSFT   261.46 (+3.45%)
META   193.14 (+26.14%)
GOOGL   106.52 (+6.06%)
AMZN   112.67 (+7.15%)
TSLA   193.18 (+6.49%)
NVDA   216.35 (+3.30%)
NIO   12.19 (+0.74%)
BABA   108.92 (-3.46%)
AMD   88.02 (+3.99%)
T   20.39 (+1.04%)
MU   63.21 (+0.97%)
F   14.48 (+5.00%)
CGC   3.16 (+2.60%)
GE   83.60 (+1.55%)
DIS   112.78 (+3.10%)
AMC   6.30 (+10.33%)
PFE   44.13 (+0.36%)
PYPL   88.04 (+6.19%)
NFLX   365.14 (+0.87%)
QQQ   311.31 (+3.45%)
AAPL   150.14 (+3.24%)
MSFT   261.46 (+3.45%)
META   193.14 (+26.14%)
GOOGL   106.52 (+6.06%)
AMZN   112.67 (+7.15%)
TSLA   193.18 (+6.49%)
NVDA   216.35 (+3.30%)
NIO   12.19 (+0.74%)
BABA   108.92 (-3.46%)
AMD   88.02 (+3.99%)
T   20.39 (+1.04%)
MU   63.21 (+0.97%)
F   14.48 (+5.00%)
CGC   3.16 (+2.60%)
GE   83.60 (+1.55%)
DIS   112.78 (+3.10%)
AMC   6.30 (+10.33%)
PFE   44.13 (+0.36%)
PYPL   88.04 (+6.19%)
NFLX   365.14 (+0.87%)
NYSE:RMED

Ra Medical Systems - RMED Stock Forecast, Price & News

$3.06
+0.04 (+1.32%)
(As of 02/2/2023 01:18 PM ET)
Add
Compare
Today's Range
$2.97
▼
$3.12
50-Day Range
$2.11
▼
$6.78
52-Week Range
$2.03
▼
$42.00
Volume
99,546 shs
Average Volume
327,636 shs
Market Capitalization
$3.34 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

RMED stock logo

About Ra Medical Systems (NYSE:RMED) Stock

Ra Medical Systems, Inc. engages in the design, development and commercialization of excimer lasers for the treatment of vascular immune-mediated inflammatory diseases. Its product, the Destruction of Arteriosclerotic Blockages by laser Radiation Ablation (DABRA) laser and single-use catheter, together referred to as DABRA, is used as a tool in the treatment of peripheral artery disease which commonly occurs in the legs. The company was founded by Dean Irwin and Melissa Burstein on September 4, 2002 and is headquartered in Carlsbad, CA.

Receive RMED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ra Medical Systems and its competitors with MarketBeat's FREE daily newsletter.

RMED Stock News Headlines

February 1, 2023 | finance.yahoo.com
Ra Medical Systems Adds Additional Clinical and Sales Representatives
January 23, 2023 | finance.yahoo.com
Ra Medical Systems Announces the Presentation of Clinical Data at the European Heart Rhythm Association Congress
February 2, 2023 | PressReach (Ad)
Top AI Tech Stock To Watch
Today's stock market news features a Robotics stock with blue sky potential.
January 23, 2023 | americanbankingnews.com
Financial Survey: Cerus (NASDAQ:CERS) vs. Ra Medical Systems (NYSE:RMED)
January 12, 2023 | forbes.com
Ra Medical Systems
January 10, 2023 | marketwatch.com
Ra Medical Systems Shares Drop 10% After Closing Catheter Precision Buy
January 10, 2023 | seekingalpha.com
Ra Medical, Catheter Precision complete merger, plan to raise up to $9.3M in equity
January 9, 2023 | finance.yahoo.com
Ra Medical Systems Completes Merger with Catheter Precision
February 2, 2023 | PressReach (Ad)
Top AI Tech Stock To Watch
Today's stock market news features a Robotics stock with blue sky potential.
December 14, 2022 | finance.yahoo.com
Ra Medical Systems Regains Compliance with NYSE American Continued Listing Standards
December 3, 2022 | marketwatch.com
Ra Medical Systems Shares Continue Rise After Thursday Data
December 1, 2022 | marketwatch.com
Ra Medical Systems Shares Rise 18% After Usage Data for VIVO Imaging System
December 1, 2022 | finance.yahoo.com
Catheter Precision’s VIVO™ System Used in More Than 800 Procedures in Leading U.S. and European Hospitals
November 29, 2022 | finance.yahoo.com
Catheter Precision’s VIVO™ Systems Used in More Than 20 Procedures at NYU Langone Hospital
November 15, 2022 | finance.yahoo.com
Ra Medical Systems Reports Third Quarter 2022 Financial Results
October 20, 2022 | finance.yahoo.com
Catheter Precision Expands U.S. Customer Base for VIVO™ for Non-invasive Arrythmia Location Detection Before Ventricular Ablation Procedures
October 17, 2022 | finance.yahoo.com
Ra Medical Systems Raises $7.6 Million Through Completed At-The-Market Facility
October 4, 2022 | finance.yahoo.com
Catheter Precision Files a Method-of-Use U.S. Patent Application for its VIVO™ Technology
September 29, 2022 | finance.yahoo.com
Catheter Precision’s VIVO™ Technology to be Featured in Three Presentations at the Global Society of Cardiac Robotic Navigation Annual Meeting
September 27, 2022 | finance.yahoo.com
Catheter Precision Names Fatih Ayoglu as Business Development Manager—EMEA
September 23, 2022 | benzinga.com
SHAREHOLDER ALERT: Weiss Law Reminds RMED, CYBE, LTRY, and TMX Shareholders About Its Ongoing Investigations
September 21, 2022 | investorplace.com
Why Was Ra Medical Systems (RMED) Stock Up 20% Today?
September 20, 2022 | finance.yahoo.com
Ra Medical Systems Announces Results of its Special Meeting of Stockholders and a 1-for-50 Reverse Stock Split
September 19, 2022 | stocknews.com
5 Penny Stocks to Sell Before They Hit Zero
September 16, 2022 | benzinga.com
SHAREHOLDER ALERT: Weiss Law Reminds RMED, CYBE, LTRY, and MSTR Shareholders About Its Ongoing Investigations
September 14, 2022 | benzinga.com
Shareholder Alert: Ademi LLP investigates whether Ra Medical Systems, Inc.'s transaction with Catheter Precision is fair to shareholders
September 13, 2022 | apnews.com
RA MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Ra Medical Systems, Inc. - RMED
See More Headlines
Receive RMED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ra Medical Systems and its competitors with MarketBeat's FREE daily newsletter.

RMED Company Calendar

Last Earnings
11/14/2022
Today
2/02/2023
Next Earnings (Estimated)
3/21/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NYSE:RMED
CUSIP
N/A
CIK
1716621
Web
www.ramed.com
Phone
(442) 245-4195
Fax
N/A
Employees
58
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($92.36)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-25,070,000.00
Net Margins
-110,533.34%
Pretax Margin
-142,047.39%
Return on Equity
-169.55%
Return on Assets
-119.65%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.83
Quick Ratio
4.83

Sales & Book Value

Annual Sales
$20,000.00
Price / Sales
166.77
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$97.53 per share
Price / Book
0.03

Miscellaneous

Outstanding Shares
1,090,000
Free Float
1,085,000
Market Cap
$3.34 million
Optionable
Not Optionable
Beta
0.05

Key Executives

  • Jonathan Will McGuireJonathan Will McGuire
    Chief Executive Officer & Director
  • Brian D. Conn
    Chief Financial & Accounting Officer
  • Alvin Memmolo
    VP-Clinical, Quality & Regulatory Affairs
  • Christopher Folk
    Vice President-Engineering
  • Maria Villanueva Sessions
    Vice President & Compliance Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Institutional Transactions













RMED Stock - Frequently Asked Questions

Should I buy or sell Ra Medical Systems stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Ra Medical Systems in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" RMED shares.
View RMED analyst ratings or view top-rated stocks.

How have RMED shares performed in 2023?

Ra Medical Systems' stock was trading at $5.89 at the beginning of the year. Since then, RMED shares have decreased by 48.7% and is now trading at $3.02.
View the best growth stocks for 2023 here.

When is Ra Medical Systems' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 21st 2023.
View our RMED earnings forecast.

How were Ra Medical Systems' earnings last quarter?

Ra Medical Systems, Inc (NYSE:RMED) released its quarterly earnings data on Monday, November, 14th. The company reported ($3.86) earnings per share for the quarter. Ra Medical Systems had a negative trailing twelve-month return on equity of 169.55% and a negative net margin of 110,533.34%.

When did Ra Medical Systems' stock split?

Ra Medical Systems shares reverse split on Monday, October 3rd 2022. The 1-50 reverse split was announced on Monday, October 3rd 2022. The number of shares owned by shareholders was adjusted after the closing bell on Monday, October 3rd 2022. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

What other stocks do shareholders of Ra Medical Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Ra Medical Systems investors own include Bionano Genomics (BNGO), Gran Tierra Energy (GTE), Matinas BioPharma (MTNB), ADMA Biologics (ADMA), CNBX Pharmaceuticals (CNBX), Novan (NOVN), Organigram (OGI), Pennsylvania Real Estate Investment Trust (PEI), CBL & Associates Properties (CBL) and Zosano Pharma (ZSAN).

When did Ra Medical Systems IPO?

(RMED) raised $50 million in an initial public offering on Thursday, September 27th 2018. The company issued 3,300,000 shares at $14.00-$16.00 per share. Piper Jaffray and Cantor acted as the underwriters for the IPO and SunTrust Robinson Humphrey, Nomura and Maxim Group were co-managers.

What is Ra Medical Systems' stock symbol?

Ra Medical Systems trades on the New York Stock Exchange (NYSE) under the ticker symbol "RMED."

How do I buy shares of Ra Medical Systems?

Shares of RMED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Ra Medical Systems' stock price today?

One share of RMED stock can currently be purchased for approximately $3.02.

How much money does Ra Medical Systems make?

Ra Medical Systems (NYSE:RMED) has a market capitalization of $3.29 million and generates $20,000.00 in revenue each year. The company earns $-25,070,000.00 in net income (profit) each year or ($92.36) on an earnings per share basis.

How can I contact Ra Medical Systems?

Ra Medical Systems' mailing address is 2070 Las Palmas Drive, Carlsbad CA, 92011. The official website for the company is www.ramed.com. The company can be reached via phone at (442) 245-4195 or via email at jcain@lhai.com.

This page (NYSE:RMED) was last updated on 2/2/2023 by MarketBeat.com Staff